PolyNovo Ltd (ASX:PNV) saw its shares soar by 5.02% during Monday's trading session following a significant change in the company's leadership. The medical technology firm announced the immediate resignation of its Chairman, David Williams, and the appointment of Non-Executive Director Leon Hoare as his successor.

According to a filing with the Australian Securities Exchange (ASX), Williams will not stand for re-election at the company's annual general meeting scheduled for Tuesday. Consequently, the resolution for his re-election has been withdrawn. The unexpected leadership transition appears to have been well-received by investors, as reflected in the stock's substantial gain.

The market's positive reaction to the news suggests that shareholders may view the leadership change as a potential catalyst for growth or improved governance. As of the latest trading update, PolyNovo's shares were maintaining their upward trajectory, signaling continued investor optimism about the company's future direction under its new chairman.